Interní Med. 2014; 16(6): 232-235

Hyperthyroidism from the perspective of clinician

doc.MUDr.Zdeněk Fryšák, CSc., doc.MUDr.David Karásek, Ph.D., MUDr.Milan Halenka, Ph.D.
III. interní klinika NRE FN a LF Olomouc

Thyroid diseases affect at least 4 times more women than men. The patients represent over 80% of those searching for the outpatient

care. Part of them suffer from some type of chronic inflammatory process, better the autoimmune, chronic thyroiditis, also known as

the lymphocytic thyroiditis, the goiter of Hashimoto. A substantial percentage of the affected patients meet the criteria of the standard

protocol as for the normal function. Scrutinizing laboratory parameters one can record suppressed TSH levels not exceptionally

accompanied by increased levels of free thyroid hormones. Sometimes there might appear a danger of being stuck at an impasse due

to inappropriately simplified differential-diagnostic approach. The possibility of inaccurate classification of the thyroid disease always

exists with the resulting problems. We will try to outline the crucial issues of hyperthyroidism in the following lines with emphasis on

the need for very careful diagnostic assessment. The end product of that process must be the correct and fair treatment plan including

the timing of the final solution.

(anti-hTG), TSH receptor antibodies (anti-rTSH), ulstrasonography (USG).

Keywords: thyrotropin (tsh), free thyroxin (ft4), free triiodothyronine (FT3), thyroperoxidase antibodies (anti-TPO), thyroglobulin antibodies

Published: December 16, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fryšák Z, Karásek D, Halenka M. Hyperthyroidism from the perspective of clinician. Interní Med. 2014;16(6):232-235.
Download citation

References

  1. Beck-Peccoz P, Brucker-Davis F, Persani L, et al. Thyrotropin-secreting pituitary tumors. Endocr Rev 1996; 17: 610. Go to original source...
  2. Beck-Peccoz P, Piscitelli G, Cattaneo MG, Faglia G. Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3'-triiodothyroacetic acid (TRIAC). J Endocrinol Invest 1983; 6: 217. Go to original source... Go to PubMed...
  3. Carney LA, Quinlan JD, West JM. Thyroid disease in pregnancy. Am Fam Physician. 2014 Feb 15; 89(4): 273-278. Review.
  4. Duprez L, Parma J, Van Sande J, et al. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 1994; 7: 396. Go to original source... Go to PubMed...
  5. Effraimidis G, Wiersinga WM. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol. 2014 Jun; 170 (6): R241-52. doi: 10.1530/EJE-140047. Epub 2014 Mar 7. Review. Go to original source... Go to PubMed...
  6. Farid NR, Kascur V, Balazs C. The human thyrotropin receptor is highly mutable: a review of gain-of-function mutations. Eur J Endocrinol 2000; 143: 25. Go to original source... Go to PubMed...
  7. Golsman J, Wietecha K, Rock J. Thyrotropin-secreting pituitary adenoma: Reduction of tumor size by octreotide therapy into the sellar confines allows surgical cure by transsphenoidal hypophysectomy. 10th Internat Cong Endocrinol, San Francisco, 12-15 June 1996, abst. no. P2-482.
  8. Horáček J, Jiskra J, Límanova Z, Springer D, Zamrazil V. Doporučení pro diagnostiku a léčbu onemocn?ní štítné žlázy v t?hotenství a pro ženy s poruchou fertility. Vnitr Lek. 2013 Oct; 59(10): 909-931. Czech. Go to PubMed...
  9. Chanson P, Weintraub BD, Harris AG. Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 1993; 119: 236. Go to original source... Go to PubMed...
  10. Iwen KA, Schröder E, Brabant G Thyroid hormones and the metabolic syndrome. Eur Thyroid J. 2013 Jun; 2(2): 83-92. Go to original source... Go to PubMed...
  11. Jiskra J, Límanová Z. Resistance to thyroid hormones. Cas Lek Cesk. 2014; 153(3): 137-141. Go to PubMed...
  12. Jiskra J. Thyreopatie po amiodaronu Kapitoly z kardiologie pro lékaře v praxi. 2003, Roč. 5, č. 3, s. 110-114. ISSN: 1212-5342.
  13. Límanová Z, Jiskra J. Contemporary theories concerning chronic lymphocytic thyroiditis.
  14. Losa M, Giovanelli M, Persani L, et al. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 1996; 81: 3084. Go to original source...
  15. Péter F, Muzsnai A. Congenital disorders of the thyroid: hypo/hyper. Pediatr Clin North Am. 2011 Oct; 58 (5): 1099-1115. Review. Go to original source... Go to PubMed...
  16. Potluková E. Štítná žláza a těhotenství. Medicína po promoci (komentář). 2012, 13(2): 55-56. ISSN: 1212-9445.
  17. Rösler A, Litvin Y, Hage C, et al. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine. J Clin Endocrinol Metab 1982; 54: 76. Go to original source... Go to PubMed...
  18. Schneider DF1, Sonderman PE, Jones MF, Ojomo KA, Chen H, Jaume JC, Elson DF, Perlman SB, Sippel RS. Failure of Radioactive Iodine in the Treatment of Hyperthyroidism. Ann Surg Oncol. 2014 Jul 8. Vnitr Lek. 2006 Oct; 52 (10): 947-953. Go to PubMed...
  19. Weinstein LS. G (s) alpha mutations in fibrous dysplasia and McCune-Albright syndrome. J Bone Miner Res. 2006 Dec; 21(Suppl 2): p120-124. Go to original source... Go to PubMed...
  20. Wiersinga WM. Graves' orbitopathy: Management of difficult cases. Indian J Endocrinol Metab. 2012 Dec; 16(Suppl 2): S150-152. Go to original source...
  21. Wiersinga WM. Smoking and thyroid. Clin Endocrinol (Oxf). 2013 Aug; 79(2): 145-151. doi: 10.1111/cen.12222. Epub 2013 May 11. Review. Go to original source... Go to PubMed...
  22. Wynne AG, Gharib H, Scheithauer BW, et al. Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients. Am J Med 1992; 92: 15. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.